iShares U.S. Pharmaceuticals ETF (IHE) is a iShares ETF with a 0.37% expense ratio, 56 holdings and $1.5B in net assets. Largest sector: Healthcare (100%).
Fee
0.37%
expense ratio
Net assets
$1.5B
Launched
May 1, 2006
Holdings
56
as of Oct 22, 2026
Top 10 weight
80.3%
largest ten holdings
Largest sector
Healthcare
100.0%
Yield
30-day SEC 1.19% · TTM 1.43%
as of Sep 30, 2026
Benchmark
DJ US Select / Pharmaceutical
IHE's holdings are as of Oct 22, 2026.
Healthcare
100.0%
1
LLY
ELI LILLY
25.43%
2
JNJ
JOHNSON + JOHNSON
21.92%
3
ZTS
ZOETIS
4.89%
4
PFE
PFIZER
4.79%
5
RPRX
ROYALTY PHARMA
4.60%
6
VTRS
VIATRIS
4.55%
7
MRK
MERCK
4.37%
8
BMY
BRISTOL-MYERS SQUIBB
4.28%
9
JAZZ
Jazz Pharmaceuticals
2.99%
10
ELAN
Elanco Animal Health
2.43%
11
CORT
Corcept Therapeutics
2.19%
12
AXSM
Axsome Therapeutics
1.49%
13
LGND
Ligand Pharmaceuticals
1.32%
14
DFTX
DEFINIUM THERAPEUTICS
1.04%
15
MANE
VeraDermics
0.93%
16
INDV
Indivior Pharmaceuticals
0.89%
17
AMRX
Amneal Pharmaceuticals
0.81%
18
OGN
Organon
0.77%
19
EWTX
Edgewise Therapeutics
0.70%
20
AMLX
Amylyx Pharmaceuticals
0.63%
21
LQDA
Liquidia
0.63%
22
TARS
Tarsus Pharmaceuticals
0.60%
23
ELVN
Enliven Therapeutics
0.57%
24
SUPN
Supernus Pharmaceuticals
0.52%
25
PBH
Prestige Consumer Healthcare
0.50%
1–25 of 56
Funds listed by how much of their largest holdings they share with IHE — not a ranking.
Data from iShares; prices and returns from market data. Page updated October 29, 2026. Holdings and figures change over time. For information only — not investment advice.